Combined Hepatocellular-cholangiocarcinoma Clinical Trials in Nanjing, Jiangsu

Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data